Who owns TOURMALINE BIO INC?
- Ticker: TRML
- CUSIP Number: 89157d105
Tip: Access positions for across all investors
Analyze quarterly positions in Tourmaline Bio with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Tourmaline Bio stock
Who bought or sold TOURMALINE BIO INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Blue Owl Capital Holdings | 1.4M | $32M | 9% | Mar 2024 |
|
Cormorant Asset Management | 1.3M | $29M | 100% | Mar 2024 |
|
Jennison Associates | 1.1M | $26M | 100% | Mar 2024 |
|
QVT Financial | 948k | $22M | 0% | Mar 2024 |
|
Vanguard Group | 915k | $21M | 20% | Mar 2024 |
|
Braidwell | 907k | $21M | 0% | Mar 2024 |
|
venBio Select Advisor | 868k | $23M | 100% | Dec 2023 |
|
Nantahala Capital Management | 701k | $16M | 71% | Mar 2024 |
|
Qiming U.S. Ventures Management | 642k | $17M | 100% | Dec 2023 |
|
Vivo Capital | 592k | $14M | 0% | Mar 2024 |
|
BlackRock | 495k | $11M | 100% | Mar 2024 |
|
Darwin Global Management | 465k | $11M | 100% | Mar 2024 |
|
Eventide Asset Management | 321k | $7.3M | 100% | Mar 2024 |
|
Velan Capital Investment Management | 319k | $7.3M | 100% | Mar 2024 |
|
Artal Group | 315k | $7.2M | 244% | Mar 2024 |
|
Ikarian Capital | 288k | $6.6M | 100% | Mar 2024 |
|
Caption Management | 243k | $5.6M | 100% | Mar 2024 |
|
FMR | 239k | $5.5M | 100% | Mar 2024 |
|
Susquehanna International | 210k | $4.8M | 100% | Mar 2024 |
|
Goldman Sachs Group | 198k | $4.5M | 2098% | Mar 2024 |
|
Citadel Advisors | 186k | $4.3M | 100% | Mar 2024 |
|
Schonfeld Strategic Advisors | 182k | $4.2M | 100% | Mar 2024 |
|
Geode Capital Management | 174k | $4.0M | 100% | Mar 2024 |
|
Woodline Partners | 157k | $3.6M | 100% | Mar 2024 |
|
Marshall Wace | 139k | $3.2M | 210% | Mar 2024 |
|
Millennium Management | 138k | $3.2M | 575% | Mar 2024 |
|
Suvretta Capital Management | 125k | $2.9M | 100% | Mar 2024 |
|
Logos Global Management | 99k | $2.3M | -65% | Mar 2024 |
|
Qube Research & Technologies | 88k | $2.0M | 100% | Mar 2024 |
|
Boothbay Fund Management | 79k | $1.8M | 100% | Mar 2024 |
|
Alyeska Investment Group | 75k | $1.7M | 100% | Mar 2024 |
|
Superstring Capital Management | 70k | $1.6M | 100% | Mar 2024 |
|
Altium Capital Management | 65k | $1.5M | 100% | Mar 2024 |
|
Hrt Financial | 61k | $1.4M | 100% | Mar 2024 |
|
AlphaCentric Advisors | 61k | $1.4M | 100% | Mar 2024 |
|
Hudson Bay Capital Management | 54k | $1.2M | 100% | Mar 2024 |
|
HighTower Advisors | 53k | $1.2M | 0% | Mar 2024 |
|
HighVista Strategies | 53k | $1.2M | 100% | Mar 2024 |
|
Man Group | 44k | $1.0M | 100% | Mar 2024 |
|
Jane Street | 40k | $919k | 100% | Mar 2024 |
|
Northern Trust | 36k | $827k | 100% | Mar 2024 |
|
Laurion Capital Management | 36k | $820k | 0% | Mar 2024 |
|
Swiss National Bank | 32k | $733k | 100% | Mar 2024 |
|
Squarepoint Ops | 27k | $619k | 100% | Mar 2024 |
|
Two Sigma Investments | 25k | $562k | -56% | Mar 2024 |
|
Two Seas Capital | 22k | $501k | 100% | Mar 2024 |
|
Two Sigma Advisers | 20k | $461k | -43% | Mar 2024 |
|
Balyasny Asset Management | 20k | $460k | -94% | Mar 2024 |
|
UBS O'Connor | 20k | $345k | 100% | Mar 2024 |
|
Credit Suisse | 19k | $429k | 100% | Mar 2024 |
|
Bridgeway Capital Management | 17k | $395k | 100% | Mar 2024 |
|
Morgan Stanley | 16k | $374k | 100% | Mar 2024 |
|
Legal & General Group | 15k | $344k | 100% | Mar 2024 |
|
American Century Companies | 15k | $337k | 100% | Mar 2024 |
|
California State Teachers Retirement System | 15k | $334k | 100% | Mar 2024 |
|
Jump Financial | 15k | $380k | 100% | Dec 2023 |
|
Tudor Investment Corporation | 13k | $305k | 100% | Mar 2024 |
|
Marathon Trading Investment Management | 13k | $300k | 100% | Mar 2024 |
|
Dimensional Fund Advisors | 13k | $299k | -37% | Mar 2024 |
|
State of Wisconsin Investment Board | 12k | $274k | 100% | Mar 2024 |
|
Henderson Group | 12k | $266k | 100% | Mar 2024 |
|
ADAR1 Capital Management | 12k | $265k | 100% | Mar 2024 |
|
Gts Securities | 11k | $257k | 100% | Mar 2024 |
|
Ubs Global Asset Management Americas | 8.9k | $204k | 100% | Mar 2024 |
|
Citigroup | 8.8k | $202k | -80% | Mar 2024 |
|
Bank of America Corporation | 7.8k | $179k | -67% | Mar 2024 |
|
Jpmorgan Chase & Co | 6.1k | $140k | 36% | Mar 2024 |
|
Denali Advisors | 5.6k | $128k | 100% | Mar 2024 |
|
China Universal Asset Management | 4.9k | $113k | 110% | Mar 2024 |
|
Barclays | 3.2k | $74k | 361% | Mar 2024 |
|
UBS Group | 2.8k | $65k | 100% | Mar 2024 |
|
Simplex Trading | 2.0k | $46k | 100% | Mar 2024 |
|
Quest Partners | 1.6k | $37k | 100% | Mar 2024 |
|
Tower Research Capital | 1.4k | $32k | 100% | Mar 2024 |
|
Bnp Paribas Arbitrage, Snc | 1.3k | $31k | 100% | Mar 2024 |
|
Quarry | 1.0k | $23k | 100% | Mar 2024 |
|
Advisor Group Holdings | 250.00 | $5.7k | 0% | Mar 2024 |
|
Federated Investors | 144.00 | $3.8k | 100% | Dec 2023 |
|
Wells Fargo & Company | 126.00 | $2.9k | 52% | Mar 2024 |
|
Rhumbline Advisers | 116.00 | $2.7k | 0% | Mar 2024 |
|
Daiwa Securities Group | 95.00 | $2.0k | 100% | Mar 2024 |
|
GAMMA Investing | 11.00 | $252.000100 | 100% | Mar 2024 |
|
NISA Investment Advisors | 7.00 | $159.999700 | 0% | Mar 2024 |
|
Who sold out of Tourmaline Bio?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Dr. Jeffrey R. Jay, M.D. | Dec 2023 | 673k | $18M |
BML Capital Management | Dec 2023 | 246k | $6.4M |
Cubist Systematic Strategies | Dec 2023 | 15k | $399k |
683 Capital Management | Dec 2023 | 13k | $350k |
Point72 Middle East FZE | Dec 2023 | 1.0k | $27k |